WOLVERINE ASSET MANAGEMENT LLC - GALENA BIOPHARMA INC ownership

GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 82 filers reported holding GALENA BIOPHARMA INC in Q3 2015. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.

Quarter-by-quarter ownership
WOLVERINE ASSET MANAGEMENT LLC ownership history of GALENA BIOPHARMA INC
ValueSharesWeighting
Q4 2015$34,000
-46.0%
21,476
-29.7%
0.00%0.0%
Q3 2015$63,000
-6.0%
30,5660.0%0.00%0.0%
Q2 2015$67,000
+2133.3%
30,566
+56503.7%
0.00%
Q1 2015$3,000
-99.5%
54
-100.0%
0.00%
-100.0%
Q4 2014$596,000
+6.4%
139,805
+28.1%
0.01%0.0%
Q3 2014$560,000
+4.1%
109,105
+33.1%
0.01%
+9.1%
Q2 2014$538,00081,9550.01%
Other shareholders
GALENA BIOPHARMA INC shareholders Q3 2015
NameSharesValueWeighting ↓
Hoxton Financial, Inc. 50,000$74,0000.04%
Alyeska Investment Group, L.P. 1,593,277$2,342,0000.02%
DUMONT & BLAKE INVESTMENT ADVISORS LLC 31,000$46,0000.02%
GROUP ONE TRADING, L.P. 1,346,904$1,980,0000.02%
Matisse Capital 17,000$25,0000.01%
COMPTON CAPITAL MANAGEMENT INC /RI 15,000$22,0000.01%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 12,150$18,0000.01%
EQUITEC SPECIALISTS, LLC 19,700$29,0000.01%
LADENBURG THALMANN FINANCIAL SERVICES INC. 153,375$225,0000.00%
OPPENHEIMER & CO INC 94,300$138,0000.00%
View complete list of GALENA BIOPHARMA INC shareholders